SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following the FDA approval of its Wegovy pill, marking a significant milestone as the first oral GLP-1 therapy for weight management. The community is buzzing with excitement, viewing this as a "game changer" that could vastly expand market access by offering a convenient alternative to injections. Many anticipate a substantial upward revaluation and a potential short squeeze, arguing the stock has been significantly undervalued relative to its sector peers.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending due to its explosive post-IPO gains, fueled by its low public float and intense speculative interest in the aerospace sector. Community chatter is highly polarized, with many celebrating its "parabolic" ascent and comparing it to past runners, while others caution it's an overhyped "pump and dump" given its limited operational history and fundamental concerns. This stark debate highlights the stock's significant volatility and high investor attention.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amidst heightened activity in the oral obesity drug market, following a competitor's oral GLP-1 approval which the community views as category-validating. Investors are actively comparing VKTX's oral VK2735, citing its strong efficacy and superior tolerability profile in early trials as a potential "best in class" contender. Discussions center on the expanding market opportunity, VKTX's pipeline progression, and the anticipation of potential partnerships or acquisitions.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent exploration drill results indicating high-grade silver in its Vortex system, significantly expanding the perceived value of its vast deposits. This news is driving community discussion around potential for a substantial short squeeze, robust institutional interest from major investors like Eric Sprott, and the broader tailwind of increasing gold and silver prices. While many are optimistic about the company's long-term prospects as a debt-free entity with considerable resources, some express caution regarding its lack of current revenue and highly elevated technical indicators.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending, fueled by its highly engaged community's belief in the "OG meme" and its lore, with many declaring it "extremely undervalued" and destined for billions. The community is actively building, expanding its presence across web3 and gaming platforms, solidifying conviction for long-term growth.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience (NAGE) is a focal point of market conversation, driven by anticipation for results from its NOPARK trial in Parkinson's disease and other clinical studies, along with expanding Niagen+ offerings. The community is actively debating the company's significant growth potential, eyeing strategic pharmaceutical partnerships and the impact of strong financial performance on its perceived undervaluation in the burgeoning NAD+ market.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is generating significant buzz due to its amended, all-cash takeover offer for Warner Bros. Discovery, now fortified by a substantial personal guarantee from Larry Ellison. This move has ignited community discussion, with many viewing PSKY's bid as a superior path to shareholder value compared to rival proposals, potentially impacting the broader media streaming market.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is actively discussed following news of securing $100 million in development financing from Macquarie, a move seen by the community as a strong validation of its AI data center strategy and a sign of imminent hyperscaler lease announcements, with some speculation around a large Louisiana project. This financing, along with upcoming earnings that are expected to confirm initial revenue from operational data centers, is driving significant bullish sentiment and anticipation of further growth in the rapidly expanding AI infrastructure sector. The ongoing volatility is also sparking conversations about potential short squeezes as the company progresses.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping is trending as its board rejected a CEO-led buyout offer, confirming receipt of multiple acquisition proposals and initiating a strategic review aimed at maximizing shareholder value. The community is actively discussing a potential bidding war, highlighting the company's substantial cash reserves and book value, which many believe indicate the stock is severely undervalued. This dynamic, coupled with high short interest, is fueling expectations for a much higher acquisition price.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust ($GBTC) is trending amidst fierce community debate over Bitcoin's price trajectory. While some warn of an impending 'crypto winter' and significant downturns citing historical cycles and institutional 'manipulation,' others see current price action as a buying opportunity, anticipating a parabolic rally and new highs for Bitcoin as a hedge against broader economic trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened

Taysha Gene Therapies (NASDAQ:TSHA) Sets New 52-Week High - Here's Why...

Taysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded Taysha Gene Therapies from a "sell" rating to a "hold" rating in a research report on Saturday...

1,203,941 Shares in Taysha Gene Therapies, Inc. $TSHA Purchased by Stempoint Capital LP

Stempoint Capital LP purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...

B Group Inc. Buys 545,000 Shares of Taysha Gene Therapies, Inc. $TSHA

B Group Inc. lifted its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 43.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Taysha Gene Therapies (NASDAQ:TSHA) Hits New 1-Year High - Here's What Happened

Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 12-Month High - Still a Buy...

Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - Here's Why

Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - Here's What Happened...

Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 7% - Still a Buy?

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 7% - Should You Buy...

TSHA FY2026 EPS Forecast Raised by Cantor Fitzgerald

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) - Investment analysts at Cantor Fitzgerald lifted their FY2026 EPS estimates for shares of Taysha Gene Therapies in a note issued to investors...

SG Americas Securities LLC Makes New $1.14 Million Investment in Taysha Gene Therapies, Inc. $TSHA

SG Americas Securities LLC purchased a new stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the second quarter, according to its most recent filing with the...

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 2.9% - Here's Why

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 2.9% - Should You Buy...

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.10	--	--	N/A
Q3 '25	-$0.09	-$0.09	-1.01%	MISSED
Q2 '25	-$0.08	-$0.09	-15.57%	MISSED
Q1 '25	-$0.09	-$0.08	8.68%	BEAT
Q4 '24	-$0.08	-$0.07	13.91%	BEAT

TSHA
Taysha Gene Therapies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TSHA News

TSHATaysha Gene Therapies Inc